SEC 13F Intelligence

Orbimed Advisors LLC / NPCE

Orbimed Advisors LLC’s Neuropace Inc Position

Does Orbimed Advisors LLC own Neuropace Inc (NPCE)? Yes — 2.10M shares worth $28M (+0.55% of its 13F portfolio) as of Q1 2026, down from 2.41M shares the prior filed quarter.

Position Value
$28M
Q1 2026
Shares
2.10M
% of Portfolio
+0.55%
Quarters Held
20
currently held

Position History NPCE

Reported value by quarter
Q2 ’21: $95MQ2 ’21Q3 ’21: $64MQ4 ’21: $40MQ1 ’22: $33MQ1 ’22Q2 ’22: $20MQ3 ’22: $15MQ4 ’22: $6MQ4 ’22Q1 ’23: $19MQ2 ’23: $18MQ3 ’23: $39MQ3 ’23Q4 ’23: $41MQ1 ’24: $53MQ2 ’24: $26MQ2 ’24Q3 ’24: $24MQ4 ’24: $38MQ1 ’25: $42MQ1 ’25Q2 ’25: $29MQ3 ’25: $27MQ4 ’25: $37MQ4 ’25Q1 ’26: $28Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20262.10M$28M+0.55%
Q4 20252.41M$37M+0.76%
Q3 20252.61M$27M+0.63%
Q2 20252.61M$29M+0.73%
Q1 20253.41M$42M+1.00%
Q4 20243.41M$38M+0.78%
Q3 20243.41M$24M+0.43%
Q2 20243.41M$26M+0.51%
Q1 20244.00M$53M+0.97%
Q4 20234.00M$41M+0.82%
Q3 20234.01M$39M+0.83%
Q2 20234.01M$18M+0.33%
Q1 20234.01M$19M+0.37%
Q4 20224.01M$6M+0.11%
Q3 20224.01M$15M+0.28%
Q2 20224.01M$20M+0.36%
Q1 20224.01M$33M+0.53%
Q4 20214.01M$40M+0.52%
Q3 20214.01M$64M+0.70%
Q2 20214.01M$95M+0.97%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Orbimed Advisors LLC’s full portfolio or all institutional holders of NPCE.